ALZI Alzai Health Corp.
Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer's Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2024 and is based in Toronto, Canada.…
Industry Peers
BiotechnologyKey Statistics
About Alzai Health (CVE: ALZI)
›
Alzai Health (CVE: ALZI) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.2650 CAD on 19 November 2026. Its 52-week range is 0.1500 CAD to 0.5000 CAD: the price is 47.0% below the high and 76.7% above the low.
Its market capitalisation is 17.17M CAD.
Alzai Health reports return on equity of 278.3%.
It holds more cash than debt, a net cash position of 1.32M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.